This article by Tom Fleischman first appeared in the Cornell Chronicle . When breast cancer metastasizes, or spreads, one of its most likely destinations is bone. In fact, four in five metastatic breast cancer patients will... Read more
A phase II trial reported in the Journal of Clinical Oncolo gy by John P. Leonard, M.D., and collaborators showed no significant progression-free survival benefit of adding bortezomib to R-CHOP. Read more
This article by Bridget Kuehn first appeared in the Cornell Chronicle . Errors in the regulation of gene expression may contribute to the development of a common form of blood cancer and point to potential treatment... Read more
Dr. Olivier Elemento , a renowned computational biologist and leader in the field of computational genomics and biomedicine, has been named director of the Caryl and Israel Englander Institute for Precision Medicine at Weill... Read more
John Babich, PhD, and collaborators have demonstrated a new way to identify and localize prostate cancer tumors while protecting healthy tissue and reducing side effects. Read the featured basic article of the September... Read more
NEW YORK (September 7, 2017) — Weill Cornell Medicine has been awarded a five-year, $11.3 million Specialized Programs of Research Excellence (SPORE) grant from the National Cancer Institute (NCI), part of the National... Read more
The Weill Cornell Medicine Specialized Programs of Research Excellence (SPORE) in Prostate Cancer, led by Mark Rubin, M.D., has been funded by the National Cancer Institute (NCI). Read more
Gail J. Roboz, M.D., discusses the impact of the FDA approval of tisagenlecleucel (CTL019; Kymriah) in select pediatric and young adult patients with a form of acute lymphoblastic leukemia (ALL). Read more
An existing drug may one day protect premenopausal women from life-altering infertility that commonly follows cancer treatments, according to a study by Ithaca member John Schimenti, Ph.D. Read more
Holly Prigerson, Ph.D., spoke about the role of truth in their fields and in society during an academic symposium to celebrate the inauguration of Cornell's 14th president, Martha E. Pollack. Read more
Ashish Saxena, M.D., Ph.D., comments on the results of a study on the use of immunotherapy to treat patients with the lung cancer mesothelioma. Read more
Meyer prostate cancer experts led by Scott Tagawa, M.D., will use Movember funds to investigate a new treatment for an advanced form of the disease. Read more